Aberrant GATA1 expression in MDS has been described with evidence of increased GATA1 expression in bone marrow CD34 + stem and progenitor cells as well as CD71 + erythroblasts from MDS patients (Maratheftis et al., 2007). The gene discussed is TFRC; the disease is myelodysplastic syndrome.